Psychedelics And Mental Health: FDA Stalls, But States Forge Ahead
Psychedelics And Mental Health: FDA Stalls, But States Forge Ahead
www.benzinga.com Psychedelics And Mental Health: FDA Stalls, But States Forge Ahead
FDA rejects MDMA for PTSD, delaying access to life-saving treatment though some states are introducing psychedelic therapy programs.
The Healing Advocacy Fund reported that over 3,500 clients received psilocybin-assisted therapy at Oregon’s first psilocybin service center in 2023. The cost of these treatments is typically much lower than what is projected for FDA-approved MDMA therapies.
0 comments